Nutritional status and body composition in children with inflammatory bowel disease: a prospective, controlled, and

S Selbuz1, A Kansu2, M Berberoğlu3

  • 1Ankara University School of Medicine, Pediatric Gastroenterology, Hepatology and Nutrition, Ankara, Turkey. kaymaksuna@gmail.com.

Insights

Most children with inflammatory bowel disease (IBD) maintain good nutrition and growth. However, some experience underweight and growth retardation (GR), with fat mass increasing over time in IBD patients compared to controls.

Area of Science:

  • Pediatric Gastroenterology
  • Nutritional Science
  • Chronic Disease Management

Background:

  • Malnutrition and growth retardation (GR) are significant complications in pediatric inflammatory bowel disease (IBD).
  • Crohn's disease (CD) is particularly associated with these extraintestinal manifestations.

Purpose of the Study:

  • To assess the nutritional status, growth, and body composition (BC) of children with IBD over a one-year period.
  • To compare these parameters between children with IBD and healthy controls.

Main Methods:

  • Prospective study involving 38 children with IBD and 57 age/sex-matched controls.
  • Evaluated anthropometry (weight, height, BMI, TSFT, mid-arm circumference) and bioelectrical impedance analysis at baseline and 1-year follow-up.
  • Assessed disease activity using clinical scoring systems and defined GR, undernutrition, severe malnutrition (SM), and obesity using standardized metrics.

Main Results:

  • 36 children with IBD and 43 controls completed the study, with most IBD patients in remission.
  • No significant changes in the frequency of GR, undernutrition, or SM were observed within the IBD group over the year.
  • While most anthropometric and BC changes did not differ between groups, fat mass (FM) showed a gradual increase in IBD patients compared to controls.

Conclusions:

  • The majority of pediatric IBD patients exhibit adequate nutrition and growth.
  • A subset of children with IBD may still present with underweight and GR.
  • IBD patients demonstrate a distinct pattern of fat mass accumulation over time relative to controls.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
576
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
873
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
801
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
403
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
703
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
86.4K